Pulmonary Defence Mechanisms Flashcards

1
Q

What are the non specific mechanisms in the airways

A

Cough reflex
Mucosa traps and cilia sweeps
Antimicrobial proteins such as lysozyme
Alveolar macrophage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Functions of pulmonary macrophages

A

• Pulmonary homoeostasis
• Removal of cellular debris
• Immune surveillance
• Microbial clearance
• Responses to infection
• Resolution of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does ontogeny mean

A

Origination and development of

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 types of Pulmonary macrophages and role

A

Alveolar macrophages - found in lumen of alveolus, directly exposed to air, phagocytosis of particles and catabolise surfactant to prevent collapse CD11C receptor

Interstitial macrophages - found in interstitium, remodel tissue, antigen present and prevent airway allergy CD11B receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the macrophages response to pulmonary diseases

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain these Immune complex-mediated lung injury types

A

(A) Normal airways
(B) Antigen inhaled in the lung is bound by its antibody. C1q binds to antibody and activates complement cascade
(C)Lung injury can also initiate inflammation by complement activation through synthesis of complement proteins from alveolar macrophages or airway epithelium
(D)Lung inflammation is exacerbated by complement
proteins that act as chemoattractants for
neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The role of pulmonary surfactant

A

• Reduces the surface tension at the air–liquid interface within the alveoli of the lung
• Maintains the fluid balance in the lung, especially across the alveolar-capillary membrane
• Transports mucus and inhaled particles, impeding their adhesion in the upper airways
• Aids pulmonary innate immune response, establishes a local barrier against infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 2 groups of proteins in surfactant

A

Hydrophilic SP-A and SP-D

Hydrophobic SP-B and SP-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the roles of SP-A and SP-D

A

Both SP-A and SP-D recognise, bind and clear pathogens enhancing their phagocytosis by innate immune cells such as alveolar macrophages and neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Roles of SP-B and SP-C

A

• SP-B and SP-C contribute to the mechanical stability of the interfacial films
• Are directly involved in the interfacial adsorption of surface-
active molecules into the air–liquid interface
• Deficiencies in, or the lack of surfactant proteins, produce severe dysfunctions in the respiratory process
• Surfactant degradation or inactivation may contribute to enhanced susceptibility to lung inflammation and infection

SP-B is especially important as total deficiency leads to death after birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lung epithelial lining fluid is rich is antimicrobial peptide which is important in…

A

Providing antiviral, antibacterial and antifungal properties

It is involved in opsonisation of bacteria and viruses by macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the anti microbial bacteria killing mechanisms

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of Anti microbial proteins and their mechanism of action

Lactoferin

SLPI

Lysozyme

Human defensins

A

Lactoferin - By binding to iron, it limits the amount of free iron for microbe growth. Inhibits biofilm formation Destabilise the outer membrane of gram-negative bacteria by binding to it.

Secretory leucoprotease inhibitor (SLPI) - Defense against destruction of pulmonary tissues by Antiviral neutrophil elastase released during degranulation at infection site. Inhibits viral DNA synthesis.

Lysozyme - Targets bacteria peptidoglycan cell wall.

Defensins - Disruption of the microbial cell membrane and metabolic disruption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is alpha-1 antitrypsin

A

• Protease inhibitor that protects lung tissues from enzymes of inflammatory cells • 0.9–2.3 g/L in blood, but the concentration can rise upon acute inflammation

• Produced in the liver and bone marrow by lymphocytic and monocytic cells in lymphoid tissue

Dampens the effect of phagocytic enzyme elastase, reducing the damage to the surrounding lung

• Neutrophil elastase breaks down harmful bacteria, but it is potentially damaging to lungs elastin if exposed, degrading the elasticity of the lungs, which results in respiratory complications such as COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What conditions can arise of alpha-1 antitrypsin

A

• Chronic obstructive
pulmonary disease
(COPD)
• Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Changes in function of alpha-1 antitrypsin

A

• Change of glutamic acid to lysine causes abnormal folding of the
protein
• 10-15% develop liver fibrosis or liver cirrhosis, because alpha-1
antitrypsin is not secreted properly and therefore accumulates in
the liver
• Cigarette smoke is especially harmful to individuals increasing
inflammation in the airways and inactivation of alpha-1 antitrypsin

17
Q

Most common immunoglobulin in secretions

A

IgA

• Forms antigen-antibody complexes
and is involved in opsonisation
• Neutralisation of pathogens by
binding to viral surface proteins that
are essential for entry of the virus into
host cells

18
Q

How do T cells in COPD and cystic fibrosis lead to parenchymal lung damage

A

In COPD or cystic fibrosis, lung epithelial cells have reduced anion transport (Cl− and HCO3−), leading to reduced airway surface liquid (ASL) volume and reduced antimicrobial activity. This can result in persistent inflammation and chronic T cell activation and proliferation, leading to parenchymal lung damage.